Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
Actual shortage: | 54 (12%) | |
Anticipated shortage: | 15 (3%) | |
Avoided shortage: | 8 (2%) | |
Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (16%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CANDESARTAN | 4MG | TABLET | Actual shortage | 2024-04-09 | 2024-04-10 | 224727 |
CANDESARTAN | 8MG | TABLET | Resolved | 2019-10-21 | 2020-01-04 | 96880 |
CANDESARTAN | 8MG | TABLET | Resolved | 2020-02-27 | 2020-05-12 | 107299 |
CANDESARTAN | 8MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114758 |
CANDESARTAN | 8MG | TABLET | Resolved | 2024-01-30 | 2024-04-23 | 217790 |
CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-25 | 2019-02-26 | 73517 |
CANDESARTAN | 16MG | TABLET | Resolved | 2019-04-09 | 2019-05-16 | 80863 |
CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-21 | 2020-05-28 | 99480 |
CANDESARTAN | 16MG | TABLET | Resolved | 2023-07-17 | 2023-09-05 | 198795 |
CANDESARTAN | 16MG | TABLET | Actual shortage | 2024-01-17 | 2024-03-07 | 216273 |
CANDESARTAN | 16MG | TABLET | Resolved | 2024-02-26 | 2024-04-23 | 220656 |
TELMISARTAN | 40MG | TABLET | Resolved | 2019-04-09 | 2019-05-16 | 80866 |
TELMISARTAN | 40MG | TABLET | Resolved | 2019-06-10 | 2019-07-20 | 86050 |
TELMISARTAN | 40MG | TABLET | Resolved | 2019-11-21 | 2020-02-04 | 99483 |
TELMISARTAN | 40MG | TABLET | Resolved | 2020-02-27 | 2020-03-19 | 107302 |
TELMISARTAN | 40MG | TABLET | Resolved | 2020-03-20 | 2020-05-12 | 109140 |
TELMISARTAN | 40MG | TABLET | Resolved | 2020-03-26 | 2020-05-12 | 109445 |
TELMISARTAN | 40MG | TABLET | Resolved | 2020-07-08 | 2020-10-21 | 119744 |
TELMISARTAN | 40MG | TABLET | Actual shortage | 2024-03-25 | 2024-04-15 | 223276 |
TELMISARTAN | 80MG | TABLET | Resolved | 2020-02-27 | 2020-03-19 | 107305 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |